Microbiota and metabolites in rheumatic diseases

Yanli Tong,Tony Marion,Georg Schett,Yubin Luo,Yi Liu
DOI: https://doi.org/10.1016/j.autrev.2020.102530
IF: 17.39
2020-08-01
Autoimmunity Reviews
Abstract:<p>As a gigantic community in the human body, the microbiota exerts pleiotropic roles in human health and disease ranging from digestion and absorption of nutrients from food, defense against infection of pathogens, to regulation of immune system development and immune homeostasis. Recent advances in "omics" studies and bioinformatics analyses have broadened our insights of the microbiota composition of the inner and other surfaces of the body and their interactions with the host. Apart from the direct contact of microbes at the mucosal barrier, metabolites produced or metabolized by the gut microbes can serve as important immune regulators or initiators in a wide variety of diseases, including gastrointestinal diseases, metabolic disorders and systemic rheumatic diseases. This review focuses on the most recent understanding of how the microbiota and metabolites shape rheumatic diseases. Studies that explore the mechanistic interplay between microbes, metabolites and the host could thereby provide clues for novel methods in the diagnosis, therapy, and prevention of rheumatic diseases.</p>
immunology
What problem does this paper attempt to address?
This paper attempts to explore the role of microbiota and its metabolites in rheumatic diseases. Specifically, the paper focuses on: 1. **The relationship between microbiota changes and rheumatic diseases**: The paper describes in detail the microbiota changes observed in patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), spondyloarthritis (SpA) and other rheumatic diseases. For example, in RA patients, the imbalance (dysbiosis) of the microbiota in the lungs, oral cavity and intestines may play an important role in the occurrence and development of the disease; in SLE patients, the diversity of the intestinal microbiota is reduced, the number of certain beneficial bacteria decreases, while the number of some potential pathogenic bacteria increases. 2. **The role of metabolites**: In addition to direct microbiota changes, the paper also emphasizes the regulatory role of metabolites produced by microorganisms on the host immune system. These metabolites can act as important immunomodulatory factors or disease - initiating factors and participate in the pathological processes of various diseases, including gastrointestinal diseases, metabolic disorders and systemic rheumatic diseases. 3. **Mechanism research**: The paper explores the interaction mechanisms among microorganisms, metabolites and the host, which may provide new clues for the diagnosis, treatment and prevention of rheumatic diseases. For example, through the activation of pattern - recognition receptors (PRR) at mucosal sites, the microbiota can affect the immune homeostasis of the host; in addition, microbial metabolites can affect the function of immune cells, such as the differentiation and activation of Th17 cells. In summary, this paper aims to comprehensively understand how microbiota and its metabolites affect the pathogenesis of rheumatic diseases and explore the potential application value of these findings in clinical practice.